JP MORGAN/CALL/PFIZER INC/64/0.1/17.01.25 Stock

Warrant

DE000JS4RH89

Real-time Bid/Ask 04:01:17 2024-05-30 EDT
0.002 EUR / 0.017 EUR +400.00% Intraday chart for JP MORGAN/CALL/PFIZER INC/64/0.1/17.01.25
3 months-60.00%
6 months-83.33%
Date Price Change
24-05-30 0.002 0.00%
24-05-29 0.002 0.00%
24-05-28 0.002 0.00%
24-05-27 0.002 0.00%
24-05-24 0.002 -33.33%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 03:14 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer J.P. Morgan
WKN JS4RH8
ISINDE000JS4RH89
Date issued 2022-12-29
Strike 64 $
Maturity 2025-01-17 (233 Days)
Parity 10 : 1
Emission price 0.4
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.47
Lowest since issue 0.001
Spread 0.015
Spread %88.24%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.82 USD
Average target price
31.92 USD
Spread / Average Target
+14.72%
Consensus